Yanlun Gu

Xueyuan Road 38
Haidian, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Global development of bispecific antibodies in oncology: a bibliometric analysis of geographic disparities, collaborative models, and emerging translational strategies.

Journal: Frontiers in immunology

Published: May 18, 2026

An orally bioavailable pan-αv/α5β1 integrin antagonist prevents aggressive prostate cancer progression via suppressing both oncogenic signals and CD47-mediated immune escape.

An orally bioavailable pan-αv/α5β1 integrin antagonist prevents aggressive prostate cancer progression via suppressing both oncogenic signals and CD47-mediated immune escape.

Journal: Molecular cancer

Published: December 25, 2025

Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization.

Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization.

Journal: eLife

Published: November 17, 2025

Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer.

Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 19, 2025

Systematic Characterisation and Analysis of Lysyl Oxidase Family Members as Drivers of Tumour Progression and Multiple Drug Resistance.

Systematic Characterisation and Analysis of Lysyl Oxidase Family Members as Drivers of Tumour Progression and Multiple Drug Resistance.

Journal: Journal of cellular and molecular medicine

Published: October 23, 2024

Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.

Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.

Journal: Advanced healthcare materials

Published: February 24, 2024

Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor-Associated Macrophage.

Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor-Associated Macrophage.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 10, 2024

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities.

IUPHAR ECR review: The cGAS-STING pathway: Novel functions beyond innate immune and emerging therapeutic opportunities.

Journal: Pharmacological research

Published: December 07, 2023

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.

Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.

Journal: Frontiers in immunology

Published: March 30, 2023

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis.

Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: March 19, 2023

A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.

A novel immunogenic cell death-related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer.

Journal: Frontiers in immunology

Published: February 10, 2023

Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.

Identification of immune-associated signatures and potential therapeutic targets for pulmonary arterial hypertension.

Journal: Journal of cellular and molecular medicine

Published: January 28, 2023

Showing 1-12 of 16

Last Updated: 09/26/2026